Cerebellar TMS for Alzheimer's Disease
Part of Brain & nervous system, Mental health clinical trials.
This trial uses a non-invasive brain stimulation technique (TMS) to target the cerebellum in people with Alzheimer's disease. It aims to see if this treatment can improve symptoms and cognitive function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 50 to 85 years
- Diagnosed with probable Alzheimer's disease (confirmed by PET scan or spinal fluid test)
- Mild to moderate Alzheimer's symptoms (MMSE score between 18 and 26, CDR score 0.5 or 1)
- Taking stable doses of Alzheimer's medications (like donepezil or memantine) for at least 12 weeks
- Have an adult caregiver who can help with the study
- Willing to sign a consent form (patient or legal guardian)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.
This study tests a non-invasive brain stimulation treatment called transcranial magnetic stimulation (TMS) to see if it can improve behavioral and psychological symptoms like agitation or mood changes in people with Alzheimer's disease. The treatment is personalized based on brain imaging and is given over several sessions.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial is testing whether a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (using magnetic fields to activate brain cells), can help improve memory and thinking in people with Alzheimer's disease. It is a potential option for those looking to explore additional treatment approaches.
This study tests whether a noninvasive magnetic brain stimulation treatment can slow down cognitive decline in people with early Alzheimer's disease. You'll receive daily sessions over several weeks, and the goal is to see if it helps preserve memory and thinking skills.
This study tests whether a brain stimulation treatment called rTMS can improve symptoms in people with Alzheimer’s disease. It mainly looks at people with mild to moderate dementia and checks whether results differ based on how the treatment is applied.
Hear when a new Transcranial Magnetic Stimulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.